Literature DB >> 20444969

Group B streptococcal disease in nonpregnant patients: emergence of highly resistant strains of serotype Ib in Taiwan in 2006 to 2008.

Ying-Hsiang Wang1, Lin-Hui Su, Jiun-Nun Hou, Tsung-Han Yang, Tzou-Yien Lin, Chishih Chu, Cheng-Hsun Chiu.   

Abstract

Among the 228 group B Streptococcus (GBS) isolates recovered in 2006 to 2008, higher resistance to erythromycin (58.3%) and clindamycin (57.9%) was found in isolates with certain resistance phenotypes. Serotype Ib isolates (24.6%) were the second most prevalent serotype, next to serotype V (29.4%), and showed the highest resistance rates to erythromycin (91.0%) and clindamycin (82.1%).

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20444969      PMCID： PMC2897481          DOI： 10.1128/JCM.00810-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  25 in total

1.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany.

Authors:  Ulrich von Both; Michael Ruess; Urban Mueller; Kirsten Fluegge; Anna Sander; Reinhard Berner
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

4.  Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan.

Authors:  W C Ko; H C Lee; L R Wang; C T Lee; A J Liu; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-05       Impact factor: 3.267

5.  Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations.

Authors:  G J Stukenborg; D P Wagner; A F Connors
Journal:  Med Care       Date:  2001-07       Impact factor: 2.983

Review 6.  Quinupristin/dalfopristin: a therapeutic review.

Authors:  D R Allington; M P Rivey
Journal:  Clin Ther       Date:  2001-01       Impact factor: 3.393

7.  Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe.

Authors:  Sylvester R Moyo; Johan A Maeland; Kåre Bergh
Journal:  J Med Microbiol       Date:  2002-07       Impact factor: 2.472

8.  Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program--North America, 2001.

Authors:  Douglas J Biedenbach; Jennifer M Stephen; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2003-08       Impact factor: 2.803

9.  Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio.

Authors:  Andrew Croak; George Abate; Kenneth Goodrum; Malcolm Modrzakowski
Journal:  Am J Obstet Gynecol       Date:  2003-05       Impact factor: 8.661

10.  Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007.

Authors:  Tami H Skoff; Monica M Farley; Susan Petit; Allen S Craig; William Schaffner; Ken Gershman; Lee H Harrison; Ruth Lynfield; Janet Mohle-Boetani; Shelley Zansky; Bernadette A Albanese; Karen Stefonek; Elizabeth R Zell; Delois Jackson; Terry Thompson; Stephanie J Schrag
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079
View more
  6 in total

1.  High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Authors:  Hui Wang; Chunjiang Zhao; Wenqiang He; Feifei Zhang; Liyan Zhang; Bin Cao; Ziyong Sun; Yingchun Xu; Qing Yang; Yaning Mei; Bijie Hu; Yunzhuo Chu; Kang Liao; Yunsong Yu; Zhidong Hu; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

2.  Human Streptococcus agalactiae strains in aquatic mammals and fish.

Authors:  Christian M J Delannoy; Margaret Crumlish; Michael C Fontaine; Jolinda Pollock; Geoff Foster; Mark P Dagleish; James F Turnbull; Ruth N Zadoks
Journal:  BMC Microbiol       Date:  2013-02-18       Impact factor: 3.605

3.  Genetic and pathogenic difference between Streptococcus agalactiae serotype Ia fish and human isolates.

Authors:  Chishih Chu; Pei-Yu Huang; Hung-Ming Chen; Ying-Hsiang Wang; I-An Tsai; Chih-Cheng Lu; Che-Chun Chen
Journal:  BMC Microbiol       Date:  2016-08-02       Impact factor: 3.605

4.  Distribution of Pilus island and antibiotic resistance genes in Streptococcus agalactiae obtained from vagina of pregnant women in Yazd, Iran.

Authors:  Mahdieh Nabavinia; Mohammad Bagher Khalili; Maryam Sadeh; Gilda Eslami; Mahmood Vakili; Nastaran Azartoos; Mahdiye Mojibiyan
Journal:  Iran J Microbiol       Date:  2020-10

5.  Prevalence of group B streptococcus colonization in pregnant women in Jiangsu, East China.

Authors:  Yanmei Ge; Fei Pan; Rui Bai; Yuan Mao; Wenli Ji; Fenfang Wang; Huacheng Tong
Journal:  BMC Infect Dis       Date:  2021-05-27       Impact factor: 3.090

6.  Capsular serotype and antibiotic resistance of group B streptococci isolated from pregnant women in Ardabil, Iran.

Authors:  E Jannati; M Roshani; M Arzanlou; S Habibzadeh; G Rahimi; R Shapuri
Journal:  Iran J Microbiol       Date:  2012-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.